The global dicyandiamide market is likely to make significant strides between 2022 and 2028, driven by the growing investments across the water treatment sector. Dicyandiamide is a nitrogen-based molecule exhibiting high reactivity. The use of this white powder is growing across numerous applications, including adhesives, dielectric coatings, powder coatings, and PVC flooring.
By grade, the market share is categorized by pharmaceutical grade, electronics grade, and industrial grade dicyandiamide, among others. The dicyandiamide market share from the pharmaceutical segment will account for a considerable portion of the total revenue by 2028. The ingredient is being used in the manufacturing of anti-diabetic drugs by leading pharma companies across the globe.
According to the data published by the International Diabetes Federation (IDF), more than 537 million adults are suffering from diabetes across the world. Of these, three out of four diabetics are living in low- and middle-income countries, signifying the promising output from pharmaceutical brands located across the BRICS (Brazil, Russia, India, China, and South Africa) nations. The growing geriatric population, alongside the high incidence of deaths due to diabetes, is fueling the pharmaceutical grade dicyandiamide market size.
By application, the industry share is divided into pharmaceuticals, flame retardants, epoxy laminates, water treatment, textile & dyeing auxiliaries, and fertilizers, among others. The fertilizers segment is expected to contribute substantially to the dicyandiamide (DCD) market share through the analysis timeline, thanks to the growing concerns around global food security. Research studies show that using dicyandiamide-based fertilizers is associated with higher plant productivity and economic gains. Both chemical as well as organic fertilizers in the liquid and dry forms can be formulated using the ingredient, whereby nitrogen loss can be prevented through nitrification.
Since the compound is deployed as a curing agent for epoxy laminates and resins, the growing demand for residential renovation activities across North America is adding to product sales. The dicyandiamide for epoxy laminates market is set to rise due to the growing spending capacity of individuals, coupled with increasing popularity of heat-cured epoxies. As the kitchen remodeling market is gaining traction worldwide amidst the pandemic, the use of dicyandiamide curing agents in countertop adhesives, sealants, concrete fasteners, and decorative molding glues, is growing steadily.
Japan dicyandiamide market forecast indicates a host of opportunities from the electronics segment, considering the high-paced technological advancement across the nation. As per the statistics published by the Japan Electronics and Information Technology Industries Association (JEITA), the Japanese electronics industry recorded a growth of nearly 93% in 2020, as compared with the 2019 figures.
China market is set for substantial growth, supported by the presence of multiple manufacturers. Chinese textile manufacturers are likely to demonstrate a growing need for these substances, which are used as affordable and effective color fixing agents for silk and other fabrics.
Benco Chemical LTD LLC, Ningxia Sunnyfield Chemical Co., Ltd., Ningxia Blue-White-Black Activated Carbon Co. Ltd., and AlzChem Group AG are some leading dicyandiamide manufacturers in the global market. These companies are expanding their distribution networks to overcome losses incurred due to the COVID-19 pandemic. They are providing a wide variety of product grades, based on the application, to international customers through online platforms.
Impact of COVID-19 on the global dicyandiamide market outlook
In 2020, the market recorded low demand due to the shutdown of commercial and trade activities across the globe. As industrial units remained shut intermittently across several regions during 2021 as well, manufacturers are focusing on strengthening their supply chains to avoid further discrepancies. As the concerns regarding the higher susceptibility of diabetic patients to the coronavirus have been growing, demand for diabetes drug metformin has increased among diabetes patients. According to a study conducted at the University of Alabama, Birmingham, administration of metformin before a COVID-19 diagnosis is linked with a threefold decline in mortality rates among type 2 patients.